# Pliant Therapeutics, Inc.: Form 8-K, filed Jun 9, 2025

- Company: [Pliant Therapeutics, Inc.](/companies/plrx.md) (CIK 1746473)
- Form: 8-K
- Filed: 2025-06-09
- Accepted by EDGAR: Jun 9, 2025, 21:29 ET
- Period: 2025-06-05
- Accession: 0001746473-25-000105
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1746473/000174647325000105/plrx-20250605.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1746473/000174647325000105/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1746473/000174647325000105/plrx-20250605.htm

Filed Jun 9, 2025.
Source: SEC EDGAR, the filing index for accession 0001746473-25-000105. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.